Supriya Lifescience Ltd.

NSE: SUPRIYA | BSE: 543434 | ISIN: INE07RO01027 | Industry: Pharmaceuticals
| Mid-range Performer
681.8000 26.55 (4.05%)
NSE Jun 20, 2025 15:31 PM
Volume: 237.1K
 

681.80
4.05%
KRChoksey
Supriya Life Science reported a quarterly revenue growth of INR 1422.7 mn in Q4FY23, compared to INR 1051.0 mn in Q3FY23. The growth was primarily supported by strong traction in the US, Europe, and Latin America markets. Therapies such as Anti Anesthetic, Anti-Allergic, and Asthmatic played a key role in driving this growth.
Supriya Lifescience Ltd. is trading below its 30 day SMA of 700.5
More from Supriya Lifescience Ltd.
Recommended